Autoimmune Haemolytic Anaemia following ChAd Ox 1 nCoV-19 in Haemodialysis.

J Assoc Physicians India

Consultant Pathologist, Rajagiri Hospital, Kochi, Kerala.

Published: January 2022

Autoimmune haemolytic anaemia (AIHA) is caused by autoantibodies that react with self-red blood cells (RBCs) and cause them to be destroyed with or without complement mediated mechanism. Its clinical presentation is heterogeneous, ranging from asymptomatic to severe forms with fatal outcomes, also it can be either idiopathic or secondary to a coexisting disorder. We report an elderly gentleman on haemodialysis, who presented with severe haemolytic anaemia after one month of first dose of ChAd Ox 1 nCoV-19 vaccine (viral vector vaccine) for SARS- CoV - 2, who also had asymptomatic COVID 19 infection around 6 months prior to vaccination. This is the first reported case of AIHA following COVISHIELD vaccine and till now there are no other reported cases from India.

Download full-text PDF

Source

Publication Analysis

Top Keywords

haemolytic anaemia
12
autoimmune haemolytic
8
chad ncov-19
8
anaemia chad
4
ncov-19 haemodialysis
4
haemodialysis autoimmune
4
anaemia aiha
4
aiha caused
4
caused autoantibodies
4
autoantibodies react
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!